NCT02039362View on ClinicalTrials.gov

Prevention of Hepatitis B Virus Vertical Transmission by Serovaccination and Tenofovir During Pregnancy

PHASE4CompletedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

January 31, 2016

Study Completion Date

July 31, 2016

Conditions
PregnancyHBV
Interventions
DRUG

Tenofovir DF

Tenofovir DF will be started at week 28 of pregnancy and stopped or not, according to the physician's decision, at week 12 after birth

Trial Locations (1)

75475

Hopital Lariboisiere, Paris

All Listed Sponsors
lead

Hopital Lariboisière

OTHER

NCT02039362 - Prevention of Hepatitis B Virus Vertical Transmission by Serovaccination and Tenofovir During Pregnancy | Biotech Hunter | Biotech Hunter